The Johns Hopkins University researchers behind two of Baltimore’s most successful biotech firms have founded a new company that has now raised $56 million to create a new diagnostic tool for cancer.
{iframe}https://www.bizjournals.com/baltimore/inno/stories/fundings/2022/11/16/haystack-oncology-city-garage-johns-hopkins.html{/iframe}